SPOTLIGHT: Drug companies direct med school research

A large number of teaching hospitals say they're willing to let drug companies take control of new pharmaceutical research, allowing them to draft journal articles and provide research results. But the schools say they're opposed to gag rules that prohibit researchers from publishing negative outcomes. Story

Suggested Articles

Biotech leaders criticized the dismissals of Chinese scientists from U.S. universities in a letter with more than 150 signatures.

In this week's EuroBiotech Report, Merck allies with Themis on vaccine R&D, Juvenescence raises $100 million and GSK files for anemia approval. 

In our EuroBiotech roundup this week, Scancell withdraws IND, Oxurion’s eye drug fails phase 2a and Abivax starts ulcerative colitis trial.